A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine against Pertussis
Open Access
- 8 February 1996
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 334 (6) , 341-349
- https://doi.org/10.1056/nejm199602083340601
Abstract
Concern about both safety and efficacy has made the use of whole-cell pertussis vaccines controversial. In some European countries, including Italy, the rate of vaccination against pertussis is low.Keywords
This publication has 29 references indexed in Scilit:
- Immunogenicity and safety of Haemophilus influenzae type b-tetanus protein conjugate vaccine alone or mixed with diphtheria-tetanus-pertussis vaccine in infantsThe Journal of Pediatrics, 1994
- Acellular Pertussis Vaccines—A Solution to the Pertussis Problem?The Journal of Infectious Diseases, 1993
- Sample size and power for prospective analysis of relative riskStatistics in Medicine, 1993
- Antibody response to Bordetella pertussis antigens after immunization with American and Canadian whole-cell vaccinesThe Journal of Pediatrics, 1992
- Efficacy of whole-cell pertussis vaccine in preschool children in the United StatesPublished by American Medical Association (AMA) ,1992
- Evaluation of Serology and Nasopharyngeal Cultures for Diagnosis of Pertussis in a Vaccine Efficacy TrialThe Journal of Infectious Diseases, 1991
- Current epidemiology of pertussis in JapanThe Pediatric Infectious Disease Journal, 1990
- Persistence of pertussis in an immunized population: Results of the Nova Scotia Enhanced Pertussis Surveillance ProgramThe Journal of Pediatrics, 1989
- Reflections on the Efficacy of Pertussis VaccinesClinical Infectious Diseases, 1987
- Protective Activities of the Filamentous Hemagglutinin and the Lymphocytosis-Promoting Factor of Bordetella pertussis in MiceThe Journal of Infectious Diseases, 1984